[1]
Elizabeth Weesner, Hosain Ghassemi, Iryna Salapenka, Jaya Sri Konakanchi, Gregory Maggio, and R. Sethi, “Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration”, kjm, vol. 15, no. 2, pp. 302–304, Aug. 2022, doi: 10.17161/kjm.vol15.17931.